|
 |
GMiA Code of Practice
Members of GMiA adhere to a high standard of behaviour and this is formalised via their compliance with the Generics Medicines Industry Code of Practice introduced 1 March 2010. The Code of Practice was granted authorisation by the Australian Competition and Consumer Commission (ACCC) on 3 November 2010.
The GMiA Code of Practice is principle based, providing guidance in a single document, on the different legislation, regulation and guidelines with which sponsors of generic medicines listed on the Australian Register of Therapeutic Goods (ARTG) comply.
The GMiA seeks to use all reasonable endeavours to provide healthcare professionals and consumers with a quick, effective and cost free method for redress of potential complaints against a member with regard to breaches of the Code.
Complaints from stakeholders should, in the first instance, be referred back to the respective member who will use all reasonable endeavours to resolve the complaint quickly and effectively. If the stakeholder is not satisfied with the action or decision of the member, the stakeholder may refer the complaint to the GMiA Code Complaint Committee via the GMiA secretariat electronically to code@gmia.com.au or by mail to PO Box 222, Pymble BC, NSW 2073.
For detailed information on the Code of Practice, please refer to the Code document posted above.
GMiA welcomes and encourages feedback from stakeholders. Feedback can be submitted electronically to code@gmia.com.au or by mail to PO Box 222, Pymble BC, NSW 2073.